BASi® | Eicosapentaenoic acid None Human Plasma

Analyte	Species	Matrix	Anticoagulant	Instrument	Aliquot Volume	LLOQ-ULOQ	Storage Temperature	Status
Eicosapentaenoic acid	Human	Plasma	None	LC-MS/MS	20 µl	400-45000 ng/mL	-20 and/or -80 °C	Active

Analyte	Eicosapentaenoic acid
Species	Human
Matrix	Plasma
Anticoagulant	None
Instrument	LC-MS/MS
Aliquot Volume	20 µl
LLOQ-ULOQ	400-45000 ng/mL
Storage Temperature	-20 and/or -80 °C
Status	Active

Tags: omega-3 fatty acid anti-inflammation prostaglandin-3 precursor thromboxane-3 precursor leukotriene-5 eicosanoids precursor docosahexaenoic acid precursor

Example in Scientific Literature

Effect of eicosapentaenoic acid and docosahexaenoic acid supplementation on C-peptide preservation in pregnant women with type-1 diabetes: randomized placebo controlled clinical trial

Supplementation with eicosapentaenoic acid and docosahexaenoic acid reduces high levels of circulating proinflammatory cytokines in aging adults: A randomized, controlled study

BASi Method Number SAP.1825

Back to all Assays